November 5 - 9, 2015
Hynes Convention Center
Boston, Massachusetts, USA
Abstract submission deadline: Thursday, September 24
Registration10:00 a.m.-6:30 p.m.
Educational Session 1: Immunotherapy 101
Session Co-Chairpersons: Jolanda de Vries, Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands, and Mary L. (Nora) Disis, University of Washington, Seattle, Washington, USA3:00 p.m.-4:30 p.m.
Immunity against cancer: How to be enhanced?Jolanda de Vries
Gene-modified T cells as biotherapeutics for cancerStephen Gottschalk, Baylor College of Medicine, Houston, Texas, USA
Immune checkpoint inhibitors: Opportunities and challengesMary L. (Nora) Disis
Educational Session 2: Mutation Profiling / Return of Genetic DataSession Co-Chairpersons: Lee J. Helman, National Cancer Institute, Bethesda, Maryland, USA, and Sharon E. Plon, Baylor College of Medicine, Houston, Texas, USA4:45 p.m.-6:15 p.m.
IntroductionLee J. Helman
National scale cancer sequencing and treatment response data integration in The NetherlandsEdwin Cuppen, University Medical Center Utrecht, Utrecht, The Netherlands
Assigning clinical meaning to genomic data for cancer precision medicineNikhil Wagle, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Delivering of the promise of personalized medicineGordon B. Mills, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Disclosing Germline Results in Cancer Studies?Sharon E. Plon
Closing remarksSharon E. Plon
Top of page